| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |